Atlas Trials

Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy

Clinical trial NCT02188277 · COMPLETED

Trial details

NCT number
NCT02188277
Sponsor
Merz Pharmaceuticals GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cerebral PalsySpastic Paraplegia and HemiparesisEquine and Equinovarus Foot Deformation
Start date
2014-07-01
Primary completion
2016-12-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.